Background: There have been no studies on the clinical characteristics and prognostic factors of pediatric ventricular tachycardia (VT).
entricular tachycardia (VT) is uncommon in children, but important because it can be degenerated to ventricular fibrillation (VF) and cause sudden death. In a previous study on out-of-hospital pediatric cardiac arrest in USA and Canada, the initial cardiac rhythm of 7% pediatric arrests was VT or VF when a rhythm was available. 1 The characteristics and spectrum of VT in children are different from those in adults, which are largely associated with ischemic heart disease. 2, 3 Pediatric VT has heterogeneous etiology and different clinical features. Moreover, the recent identification of the genetic predisposition for ventricular arrhythmia and the advanced ablation technique for arrhythmogenic substrate may influence the patient profile of pediatric VT as well as the outcome. 4 Some studies have investigated VT in a normal heart, VT in association with congenital heart disease (CHD) or surgical repairs and VT with genetic causes. However, the clinical characteristics and the differential prognosis among pediatric VT categories in a population have not been well identified.
This study aimed to elucidate the clinical characteristics and outcome of pediatric VT according to clinical category, and risk factors of sudden cardiac death or cardiac arrest.
Methods
Eighty-one patients (0-19 years; 50 males, 31 females) with documented VT who had visited Seoul National University Children's Hospital in Korea from January 1999 to March 2009 were enrolled in the study. The median follow-up period for the entire group was 6.0 years (range, 0.7-23.5 years) and 618.1 patient-years. The medical records provided a detailed history and diagnosis for all patients, including onset age, symptoms during the VT attack, VT ECG (morphology, duration, heart rate and axis), 24-h Holter monitoring, Treadmill test (TMT), echocardiogram finding, resting ECG, acute management, long-term management and follow-up data. Patients with early transient postoperative VT that occurred within 30 days after cardiac surgery, those unproven by ECG, those with accelerated ventricular rhythm and those that were lost to follow-up were excluded from the study. Patients with con-SONG MK et al.
genital long QT syndrome who did not have documented VT ECG recordings despite syncope were also excluded. The patients were grouped into the following 6 categories: idiopathic VT (IVT; n=37; 46%), catecholaminergic polymorphic VT (CPVT; n=10; 12%), CHD-associated VT (CHD-VT; n=15; 18%), myocarditis-associated VT (MC-VT; n=8; 10%), cardiomyopathy-associated VT (CMP-VT; n=5; 6%) and miscellaneous (n=6; 8%). The miscellaneous group included 2 patients (siblings) with Andersen syndrome, 1 patient with drug-induced long QT syndrome, 1 patient with left ventricular (LV) cardiac fibroma, 1 patient with VT associated with epicardial pacemaker lead and 1 patient with bradycardia-related QT prolongation who had Wegener's granulomatosis and chronic renal failure. IVT was defined as VT without any identifiable etiology in a structurally normal heart. CPVT is characterized by exercise-or emotional stressinduced polymorphic VT in the absence of detectable organic heart disease with normal baseline ECG. The CHD-VT group contained patients presenting with preoperative VT as well as late postoperative VT.
The diagnosis of VT was based on documentation of at least 3 consecutive ventricular premature beats at a rate higher than 120 beats/min on an ECG or 24-h Holter monitoring. VT was classified by the duration of VT and QRS morphology as described previously: 5 monomorphic VT or polymorphic VT, sustained VT or nonsustained VT and VT with right bundle branch block pattern (VT-RB) or VT with left bundle branch block pattern (VT-LB).
The patients were sorted into the following 4 groups according to the long-term treatment method: antiarrhythmic drug (AAD) only, radiofrequency catheter ablation (RFCA), implantable cardioverter defibrillator (ICD) and surgery. Patients in the ICD groups were kept on AAD if needed. The outcomes are defined as follows: (1) resolved, there were no more symptoms of VT or VT could not be proven for more than 1 year after treatment; (2) spontaneous resolution, the symptoms disappeared without treatment and VT could not be proven; (3) partial resolution, the frequency of VT symptoms decreased but persisted regardless of treatment; (4) no change, VT persisted without treatment (observed in cases of asymptomatic nonsustained VT).
Statistical Analysis
Baseline characteristics of the patients and VT type were compared using chi-square tests and Fisher's exact tests for the categorical variables. The differences between the mean age values of the groups were examined using the KruskallWallis test. The factors for successfully resolved VT and risk factors of death or rescued cardiac arrest were evaluated using chi-squared tests and multivariate logistic regression analyses. The death or cardiac arrest-free survival was graphically displayed according to the method of life table analysis.
Results

Patient Characteristics
The median age of onset of VT symptoms was 9.0 years (range, 0.1-18 years) and that of diagnosis as VT was 10.0 years (range, 0.1-22 years). VT was frequently observed in infancy and teenagers (Figure 1) . Distinctively, the distribution of onset age of patients with IVT-RB had 2 peaksinfancy and adolescence. There was a statistically significant difference between the onset ages of clinical categories (P= 0.041; Kruskall-Wallis test) ( Table 1 ). The median onset age was the lowest in patients with MC-VT at 2.7 years (range, 0.1-12.9 years). The median onset age of CPVT was the early school age (median, 7.5 years; range, 1.2-10.4 years) and those of CHD-VT and CMP-VT were higher than in the other groups. Fourteen children (17%) were initially misdiagnosed before being correctly diagnosed with VT. Of these, 5 patients (13.5%) with IVT were misdiagnosed as having paroxysmal supraventricular tachycardia and 7 patients (70%) with CPVT were misdiagnosed as having epilepsy.
The presenting symptoms were palpitation (27) , syncope (24), cardiac arrest (13) and seizure (7) . However, 18 patients were asymptomatic and 10 patients presented with only nonspecific discomfort such as irritability, tachy-dyspnea, lethargy and diaphoresis. While palpitations were reported mainly by children and adolescents over 10 years of age (P= 0.001), nonspecific discomforts (median, 0.7 years; range, 0.2-6.8 years) were often the only sign of VT in very young children. However, the other symptoms such as syncope and seizure did not differ in frequency across the different age groups. Table 1 shows the clinical characteristics of patients with VT. We observed that all patients with CPVT experienced recurrent episodes of syncope. Seizure-like events also occurred mainly in patients with CPVT (P=0.001). Cardiac arrest occurred in 2 patients with IVT, 4 with CPVT, 1 with CHD-VT, 1 with MC-VT and 3 with CMP-VT (P=0.012). Hypoxic- The provoking factors of VT were found in 44% of the patients in this study; exercise in 25, emotional stress in 6, fever in 3 and general anesthesia in 2 patients. Two patients had drug-related VT (risperidone and pethidine (Demerol ® )).
Two patients had a family history of sudden cardiac death. One patient, whose father died from sudden cardiac death, had sustained IVT-LB although there was no documented evidence of arrhythmogenic RV dysplasia by echocardiography and cardiac MRI. The other patient's brother had sudden cardiac death and the mother presented with recurrent syncope; this patient had CPVT. The siblings with Andersen syndrome had asymptomatic NSVT.
ECG Characteristics of VT
The mean QRS duration of VT was 119±23 ms (range, 70-180 ms) and the mean heart rate during VT was 188± 38 beat/min (range, 128-340 beat/min). The ECG characteristics of VT are summarized in Table 2 . Sustained VT and nonsustained VT were observed in 54 and 26 patients respectively. Monomorphic VT was noted in 62 patients (77%) and polymorphic VT in 19 patients (23%). This difference was statistically significant among the clinical categories (P< 0.001). All patients with IVT and CHD-VT presented with monomorphic VT. However, in the CMP-VT group, 4 out of 5 patients had polymorphic VT. The origin of VT was statistically different across the clinical categories (P=0.008). VT-LB was more frequently nonsustained than VT-RB (61% vs 8%, respectively, P=0.001).
Management and Arrhythmia Characteristics
Forty-two patients (52%) needed emergent management such as intravenous AAD or DC cardioversion to terminate VT; of these, 41 cases had sustained VT. Among the sustained IVT group (27), 20 patients required emergent management. While 10 patients recovered to a sinus rhythm after the first DC cardioversion, 6 patients required another IV drug after several cardioversions. Emergent RFCA was performed for a patient with medically intractable IVT-RB. The other patient with sustained IVT-RB, which was complicated by tachycardia-induced cardiomyopathy and torsade de pointes because of amiodarone toxicity at another hospital, was also successfully managed by emergent RFCA. Eight patients (53%) with CHD-VT, 4 (50%) with MC-VT and 4 (80%) with CMP-VT needed acute management, although this did not affect the incidence of death or cardiac arrest.
Further long-term treatment for VT was administered to 69 patients (85%) and 12 patients (15%) were observed without treatment. Figure 2 shows the long-term treatment and outcome according to clinical category.
(1) IVT (n=37) The QRS axis of IVT-LB was inferior at the frontal plane indicating the RV outflow tract (RVOT) origin in 12 out of 13 patients. All cases with IVT-RB, except for 1, had superior axis morphology. The origin of IVT did not differ across age. In the IVT group (37), 20 patients took AAD medication only and their median onset age was 6.2 years. Infant-onset IVT-RB disappeared spontaneously or after taking medication for several years. The median time to resolution of infant-onset IVT was 1.4 years (range, 0.1-2.5 years) and the mean age of resolution was 1.9±1.1 years (range, 0.1-3.2 years). RFCA was performed in 14 pa- IVT, idiopathic ventricular tachycardia (VT); CPVT, catecholaminergic polymorphic VT; CHD-VT, congenital heart disease-associated VT; MC-VT, myocarditis-associated VT; CMP-VT, cardiomyopathy-associated VT; HIE, hypoxic ischemic encephalopathy. *Onset age was compared with Kruskall-Wallis test. Other P-values were examined using chi-square test. (2) CPVT (n=10) The ECG morphology of CPVT was polymorphic or bidirectional. All patients with CPVT had experienced syncope and were treated with β-blockers. Despite receiving β-blocker therapy, 4 patients experienced cardiac arrest and 2 of them died suddenly. ICD implantation was required in 1 patient.
(3) CHD-VT (n=15) Two patients with CHD experienced VT before surgical repair and 13 patients had VT after heart surgery. The median interval from the time of open heart surgery to the development of VT was 9.7 years (range, 1 month -15 years). The congenital heart defects associated with late postoperative VT were tetralogy of Fallot (TOF) (6/13), double outlet of right ventricle (4/13), ventricular septal defect (3/13) and coronary arteriovenous fistula (1/13). Surgical ablation for VT circuit or ICD implantation was carried out in about half of the patients in this group.
(4) MC-VT (n=8) These patients presented with VT at the acute stage of myocarditis, accompanying heart failure in 3 patients. They were provided supportive care such as inotropic therapy and emergent management for VT. After recovery from the acute stage, half of the patients were administered medications such as amiodarone or β-blockers and all patients were able to discontinue these drugs without recurrence of VT.
(5) CMP-VT (n=5) This group comprised 1 patient with hypertrophic cardiomyopathy (HCMP), 2 with idiopathic DCMP, 1 with uremic cardiomyopathy and 1 with isolated noncompaction of the LV. Two patients experienced torsade de pointes associated with QT prolongation during inotropic therapy. ICDs were implanted in 2 patients with a history of syncope or following rescue from cardiac arrest. One of these patients received appropriate ICD shock therapy 2 times within 2 years. Two patients died suddenly and 1 with DCMP died of incessant VT.
Outcome and Prognostic Factors
The prognosis was excellent in the RFCA and surgery groups. VT did not recur in any of the patients (including 1patient with dual VT foci who underwent 2 sessions of RFCA) during the follow-up period after the procedure. VT was resolved in 53% of the patients treated with AAD only and in 58% of the patients without treatment. The onset age of infancy (P= 0.044), VT categories of IVT and MC (P=0.000) and transcatheter/surgical ablation (P=0.000) were the factors for the successful resolution of VT (which is not shown). Monomorphic VT was more successfully controlled than polymorphic VT (P<0.001). Asymptomatic VT, the origin of VT and nonsustained VT was not significantly associated with the successful resolution of VT.
The overall mortality rate of pediatric VT was 7.4%. In the CMP-VT and CPVT groups, the cardiac arrest-free survival rate was lower than that in the other groups (P<0.001) (Figure 3) . The expected life span of patients without cardiac arrest was less than 4 years in the CMP-VT group. For CPVT, the 10-year-survival rate without cardiac arrest was Table 1 .
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approximately 55%. In contrast, the long-term outcome of patients with IVT, MC-VT and CHD-VT was good after proper management for VT or heart failure. Table 3 shows the risk factors for sudden death or rescued cardiac arrest in children with VT. The incidence of death or cardiac arrest was not related to gender distribution or onset age. However, large significant differences were found in the patients with respect to clinical categories, VT type, symptoms and TMT results. Sudden death and cardiac arrest were more frequently developed in patients with CPVT, CMP-VT, sustained VT (P= 0.026), polymorphic VT (P=0.000), syncope (P=0.009), seizure (P=0.011) and provoked VT on TMT (P=0.011). Among the 18 asymptomatic patients, VT disappeared in 13 cases and the frequency of VT episodes decreased in 3 cases. VT persisted in 2 patients with Andersen syndrome and in 1 patient who had noncompaction LV and chromosomal anomaly. In order to evaluate the role of possible risk factors for 
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sudden death or cardiac arrest, a logistic regression model was used ( 
Discussion
This study describes the clinical characteristics and prognostic factors of VT in Korean children. The patients were classified into the following 6 categories: IVT, CPVT, CHD-VT, MC-VT, CMP-VT and miscellaneous. We demonstrated that the clinical features and prognosis of pediatric VT differed according to the VT type, clinical categories and onset age.
IVT was found to be the most common form (46%) in the observed cases of pediatric VT. This differs from IVT in adults, where it has been reported to account for 10% of adult VT cases, as evaluated by electrophysiological studies in centers in USA 6 and for 20% of those in Japan. 7 Furthermore, the most common form of adult VT was associated with ischemic heart disease. 2 However, previous studies on adult Korean populations revealed that the most common VT was IVT (54.4%), similar to the case observed in the children in our study. 8 In this study, 65% of the IVT cases had RBBB configuration and the remainder had VT-LB; these results differ from those of previous studies in adults whose monomorphic IVT usually had a LBBB configuration. 2,6,9 In the present study, the axis of IVT-RB was superior in 23 out of 24 patients with IVT-RB, indicating that it could originate from the left posterior fascicle. Of the 9 patients with IVT-RB who received IV verapamil, 8 were responsive. The mechanism of these was considered to be verapamilsensitive reentry. 7 But 2 of the 4 patients with VT arising from RVOT and 2 patients with IVT-RB were sensitive to adenosine, suggesting that the triggered activity may be the underlying mechanism. 10, 11 Our results showed that the most common IVT in children was VT arising from LV and most of them originated from the left posterior fascicle. In the children with IVT, 61% of the IVT-LB cases and 8% of the IVT-RB cases were nonsustained. Nonsustained IVT originated mainly from the RV rather than the LV (P=0.001), which is consistent with an earlier study. 12 In the present study, 27% of IVT patients had nonsustained VT, which was different from school-based heart disease screening in Japan, describing that 90% in healthy children diagnosed as VT had nonsustained VT. 13 It is because our data was from a single tertiary hospital where most patients were referred from other hospitals and many of them had symptoms.
IVT is generally known to have a good prognosis. 9,14 Some studies have reported that in the absence of underlying heart disease, VT in children may not need treatment and may resolve itself spontaneously. 15-17 However, Deal et al reported the mortality of children with IVT as 13%. 18 In this study, a patient with IVT suddenly died and fatal events such as syncope and cardiac arrest occurred in 5 of the patients (13.5%) with sustained IVT. Incessant tachycardia leading to a tachycardia-induced cardiomyopathy was also found in 1 patient; this has been described previously. 19 Therefore, patients with IVT need to be evaluated thoroughly and aggressive treatment should be considered. RFCA has been reported to be a good treatment method for IVT, 20-22 which was confirmed again in the present study. An elective ablation procedure for recurrent symptomatic IVT may be considered in adolescents as a first line of therapy in experienced centers. In contrast, infant-onset IVT-RB had such excellent prognosis that it resolved spontaneously or after administration of AADs in most infants within 2 years, which has also been described in a previous study. 12 CPVT is a highly malignant form of inherited arrhythmogenic disease. Causing the autosomal-dominant and recessive forms of CPVT, mutations in genes encoding cardiac ryanodine type 2 receptor (RYR2) and calsequestrin 2 (CASQ2) were found. [23] [24] [25] In this study CPVT was presented in early school age and the incidence of cardiac arrest or sudden death during the follow-up period was 40%. All patients with CPVT except 1 showed symptomatic improvement after treatment with a β-blocker (propranolol, metoprolol and atenolol), but the life-threatening events were not completely prevented. One CPVT patient, who underwent ICD implantation because of recurrent syncope despite a high dose of β-blockers, experienced electrical storm due to incessant VT episodes in a state of panic resulting from the ICD shock itself. After the period of this study, thoracoscopic left sympathetic denervation procedures were performed in 3 patients, including the patient with the implanted ICD. Further follow-up of these patients is required. Other genetic ionic channelopathies such as long QT syndrome and Brugada syndrome have been identified as the cause of lethal cardiac arrhythmia. 26 However, they were not included in this study because of the lack of documented VT ECG.
VT can develop late after the repair of CHD, especially in the TOF. Sustained VT in the CHD-VT group is related to sudden death and has been observed after virtually all ventricular operations. 27,28 Sustained VT appears to be the biggest contributor in the incidence of late cardiac death after repair of CHD. 29 Several clinical variables with modest prognostic value have been identified for sudden death in patients with postoperative VT in the TOF, including older age at time of surgery, inducible VT at electrophysiological study, high-grade ventricular ectopy and wide QRS (>180 ms). 29 In the present study, however, only 1 patient who underwent repair of double outlet of right ventricle and residual subaortic stenosis, and was waiting for reoperation, died of VT. Because transcatheter ablation and pharmacologic treatment are known to be unsuccessful for treating CHD-VT, surgical cryoablation was applied in patients with concomitant hemodynamic problems such as severe pulmonary regurgitation. ICD has been effective to prevent sudden death in several patients with CHD, including VT in the TOF. 30, 31 All late postsurgical episodes of sustained VT were treated aggressively with ICD implantation or surgical cryoablation in our series. In some centers, postoperative VT was treated with RFCA successfully, but indication was limited because of an inability to induce stable VT for precision mapping and certain high-risk VT locations. 29,32, 33 Nollert et al reported that in 490 patients with TOF who survived the first year after operation, the annual mortality increased 25 years postoperatively from 0.24%/year to 0.94%/year (P=0.003). 34 Because the follow-up duration for CHD-VT was 14.4±7.5 years in the present study, a longer follow-up is necessary. One patient with epicardial pacemaker lead-induced VT, in which the damaged myocardium by the lead tip was presumed to be the substrate for VT, was also successfully treated by lead extraction and surgical cryoablation of VT focus. 35 The outcomes of CPVT and CMP-VT were poorer than Pediatric Ventricular Tachycardia that of IVT (CPVT: OR, 11.7; 95%CI, 1.7-78.4; CMP-VT: OR, 70; 95%CI, 5.1-955.6). Cardiac arrest or death was observed more frequently in patients with CPVT or CMP-VT than in patients from the other groups. With respect to the VT type, the polymorphic and sustained forms of VT had worse prognosis. In contrast, the origin and rate of VT did not influence the nature of the patient's symptoms and prognosis; these findings were different from those reported previously. 36, 37 In the univariate correlation analysis, symptoms such as syncope and seizure, and provoked VT in TMT had a statistical relation to poor outcome, but in the multivatiate analysis, clinical category and VT type had a more effective predictive value for death or cardiac arrest than previous factors. Although VT has been known to occur frequently in patients with mitral valve prolapse syndrome or arrhythmogenic RV dysplasia, 38-41 none of the patients in the present study presented with these conditions. This may be influenced by the racial difference and age.
This study is limited by its retrospective nature and the time span of the data collection. Since the whole group and the subgroups were all smaller than 100, the results could have diluted the information. Furthermore, the data was from a single tertiary center, which might not represent the VT distribution of children and asymptomatic unsustained IVT could be dropped. Since most of the patients did not received cardiac MRI, focal structural and wall motion abnormalities of ventricle could not be excluded. Some patients had only 2-or 3-lead ECG without a 12-lead ECG during VT and so the analysis of the VT type remained incomplete. Because we enrolled patients with documented VT ECG, our result could not be extrapolated to the total population of ventricular arrhythmia such as long QT syndrome and sudden death following surgical repair of a congenital heart defect.
Conclusion
VT is a potentially life-threatening arrhythmia because it leads to VF and sudden cardiac arrest. Pediatric VT is different from adult VT in respect to the characteristics, clinical spectrum and management. Prognosis depends on the clinical category, VT type, age and treatment method. The best outcome can be achieved by accurate diagnosis and proper management according to clinical category and VT characteristics.
